Keynote Information

Celebrating its 10th successful year, SCOPE Summit 2019 takes place February 18-21 in Orlando, FL. Over the course of four stimulating days of in-depth discussions in 19 different conferences, 3 plenary keynote sessions, and the ever-popular interactive breakout discussions, the programming focuses on advances and innovative solutions in all aspects of clinical trial planning, management and operations, including: Site Selection and Management, Patient Engagement, Recruitment and Retention, Protocol Optimization, Feasibility, Data Strategy & Analytics, Artificial Intelligence (AI), Sensors and Wearables, Project Management, Outsourcing, Forecasting, Budgeting and Contracting, Quality (QbD) in Trial Conduct, Risk-Based Monitoring, Post-Marketing Studies, Observational Research, Clinical Biomarker Strategy, Clinical Supply Chain, Precision Medicine, and Biospecimens and Central Lab Solutions. SCOPE attracted 1,700 leaders in clinical operations and research in 2018 and each of our conference tracks will feature best practice case studies relevant to clinical operations experts and those new to the field.

Monday, February 18, 2019


2:00-5:00 pm User Group Meetings & Hosted Workshops (opportunities available):

5:00 Pre-Conference Plenary Keynote Opening Remarks

Speaker to be Announced

5:05 Empowering Humans to Own Their Own Data

Speaker to be Announced, Verily Life Sciences
Shwen Gwee, General Manager, Digital Accelerator, Global Drug Development, Novartis

5:30 SCOPE’s 2019 Participant Engagement Awards Introduction

Speaker to be Announced

5:35 SCOPE’s 2019 Participant Engagement Awards

In Memory of Jerry Matczak, #BeLikeJerry, #SCOPE2019
Creativity and Engagement in Recruitment and Retention Communications
Designed to inspire innovation and change in how the industry communicates with participants in the fields of recruitment and retention in clinical trials, this award embodies the values and personal accomplishments of Jerry Matczak, who sadly passed away soon after receiving the 2017 award. We dedicate this award to Jerry in the hopes that it will serve as a reminder of his ideals and accomplishments.
Submit your work only now:

Chairperson: David Sall, President & CEO, Patient Enrollment Advisors; Co-Creator of the SCOPE Participant Engagement Award
Angela Radcliffe, GM, Clinical Trial Solutions, PulsePoint
Kelly McKee, Head, Patient Recruitment, Vertex; Co-Creator of the SCOPE Participant Engagement Award
Shwen Gwee, General Manager, Digital Accelerator, Novartis
David Fuehrer, CEO, GRYT Health, two-time cancer survivor
Joe Kim, Senior Advisor, Patient Experience and Design Innovation, Eli Lilly
Micah Lieberman, Executive Director, Conferences, Cambridge Healthtech Institute (CHI)

6:05 SCOPE’S Kick-Off Networking Happy Hour

Tuesday, February 19, 2019


8:15 Organizer's Welcome

Micah Lieberman, Executive Director, Conferences Cambridge Healthtech Institute (CHI)

8:20 Chairpersons” Introduction

Matt Miller, President, Co-Founder, StudyKIK
Jerome Chiaro, Chief Patient Advocate, Co-Founder, StudyKIK

8:25 Keynote Kick-Off: Digital Trends That Are Changing the Healthcare Experience

Shwen Gwee, General Manager, Digital Accelerator, Global Drug Development, Novartis

8:45 Do Engagement Tools Live Up to their Hype? Doctor and Patient Perspectives on Study Participation

Moderator: Bonnie Brescia, Founding Principal, BBK Worldwide
Doctor: Elliot Rosenstein, MD, Institute for Rheumatic and Autoimmune Disease at Overlook Medical Center (not confirmed)
Patient: Annie Finstein (not confirmed)

It is generally thought that engagement programs (e.g., apps, travel, and reimbursement tools) enhance the patient and site experience within a clinical research study. But do they really? This interactive session will feature a doctor and a patient who can provide first-hand insight into using these engagements tools and what their effectiveness truly is. This session will be part of BBK Worldwide's Pharma15 Live! web series that tackles some of today's most compelling issues and brings them to the forefront for discussion.

  • Perspectives from a doctor and a patient regarding usage of engagement tools - i.e. travel and reimbursement apps
  • Shifting the conversation from return-on-investment to return-on-impact.

9:15 INTERACTIVE PANEL: Why Do We Need Caregivers in Clinical Trials; Exploring Real-life Applications in Engagement and Retention

Moderator: Lynne Becker, Senior Data Analyst, Enterprise Intelligence & Data Solutions (EIDS) Program Management Office (PMO), Deputy Assistant Director Information Operations, Defense Health Agency (DHA)
Patient-Centered Outcomes Research Institute (PCORI)
Chris O'Brien, MBA, Vice President, myHealthTeams, Board Member, MHE Research Foundation
Panelist to Be Announced

Why do we need caregivers in clinical trials? We have oversimplified our lifestyles in many areas but burdened our healthcare. Persons became doctors or nurses to care for others, delivering empathy to their patients. Technology is inhibiting, perhaps limiting these touchpoints leaving patients to search for compassionate care. Caregivers are quickly becoming essential to a person's healthcare as well as to complex, confusing and overwhelmingly clinical trials. How do we integrate this new and essential component in helping us achieve successful clinical trial experiences?

  • What a caregiver is not...Are caregivers an extension of a healthline or a patient? Are there legal or ethical implications?
  • How involved can a caregiver be? Should they be compensated?
  • Who chooses a caregiver? What are the HIPPA or IRB challenges?

9:45-10:45 Grand Opening Coffee Break in the Exhibit Hall

Wednesday, February 20, 2019


2:10 Organizer's Welcome

Micah Lieberman, Executive Director, Conferences Cambridge Healthtech Institute (CHI)

2:15 Chairperson's Introduction

Speaker to be Announced

2:20 INTERACTIVE PANEL: Welcome, Pharma, to AI. Here’s What You Have Been Missing.

Moderator: David Vulcano, MBA, VP Research Compliance & Development, Hospital Corporation of America (HCA)
Edmund Jackson PhD, VP & Chief Data Scientist, Hospital Corporation of America (HCA)
Ron Williams, CEO, Business Evolutions
Balazs Flink, MD, Head, Clinical Trial Analytics, Bristol-Myers Squibb

Artificial intelligence (AI) has been utilized in other industries outside of life sciences with varying degrees of sophistication. As pharma learns AI’s place in the life sciences industry, it may benefit from learning what other large companies have accomplished with AI and their lessons learned.

  • How are healthcare delivery systems using AI to better deliver care and improve efficiencies?
  • What similar problems have non-healthcare industries solved with AI?

2:50 INTERACTIVE PANEL: Patient Centricity and Data Permissions

Moderator: Craig Lipset, Head, Clinical Innovation, Pfizer
Michelle Shogren, Head of Innovation in Portfolio and Operations, Bayer

Lauren Bataille, Senior Associate Director, Research Partnerships, The Michael J. Fox Foundation for Parkinson's Research

Laurie Myers, Global Health Literacy Director, Merck (MSD)

Jane Perlmutter, PhD, President & Founder, Gemini Group

The Patient Centricity and Data Permissions panel will feature technologies and approaches to enable patient centricity of clinical trials and to ensure the patient data rights and good practices.

  • Building a patient-centric framework that is both effective and compliant
  • Converging patient-facing technology capabilities, the real challenges
  • Streamlining direct-to-patient activities and creating a user experience to improve research and outcomes
  • Creating the infrastructure to comply with best practices for patient data rights and permissions

3:20-4:05 Refreshment Break in the Exhibit Hall, Last Chance for Exhibit Viewing

Signature Sponsor


Premier Sponsors







PRA Health Sciences


Syneos Health